Search Results - "Girre, V"

Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review by PUTS, M. T. E, HARDT, J, MONETTE, J, GIRRE, V, SPRINGALL, E, ALIBHAI, S. M. H

“…Geriatric assessment is a multidisciplinary diagnostic process that evaluates the older adult's medical, psychological, social, and functional capacity. No…”
Get full text

An update on a systematic review of the use of geriatric assessment for older adults in oncology by Puts, M.T.E., Santos, B., Hardt, J., Monette, J., Girre, V., Atenafu, E.G., Springall, E., Alibhai, S.M.H.

“…Our previous systematic review of geriatric assessment (GA) in oncology included a literature search up to November 2010. However, the quickly evolving field…”
Get full text

Survival of breast cancer patients with meningeal carcinomatosis by Gauthier, H., Guilhaume, M.N., Bidard, F.C., Pierga, J.Y., Girre, V., Cottu, P.H., Laurence, V., Livartowski, A., Mignot, L., Diéras, V.

“…Breast cancer is the leading nonhematologic cause of meningeal carcinomatosis (MC). The aim of this study was to report the outcome of patients diagnosed with…”
Get full text

Cabazitaxel in patients with advanced solid tumours: Results of a Phase I and pharmacokinetic study by Diéras, V, Lortholary, A, Laurence, V, Delva, R, Girre, V, Livartowski, A, Assadourian, S, Semiond, D, Pierga, J.Y

“…Abstract Background Although the taxanes paclitaxel and docetaxel are among the most active agents for the treatment of a wide range of cancers, tumours often…”
Get full text

BS.2 How to build up a Geriatric Oncology Program by Girre, V

Get full text

Pharmacokinetics and toxicity of docetaxel: Role of CYP3A, MDR1, and GST polymorphisms by Tran, A., Jullien, V., Alexandre, J., Rey, E., Rabillon, F., Girre, V., Dieras, V., Pons, G., Goldwasser, F., Tréluyer, J.M.

“…Objective Patients initiating docetaxel chemotherapy were genotyped for CYP3A4, CYP3A5, MDR1, GSTM1, GSTT1, GSTM3, and GSTP1 to identify variability factors of…”
Get full text

Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study by Puts, M.T.E., Monette, J., Girre, V., Wolfson, C., Monette, M., Batist, G., Bergman, H.

“…The aim of this prospective study was to report the quality of life (QoL) of older cancer patients during the first year after diagnosis and factors…”
Get full text

Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy by Diéras, V., Limentani, S., Romieu, G., Tubiana-Hulin, M., Lortholary, A., Kaufman, P., Girre, V., Besenval, M., Valero, V.

“…Treatment options are limited for patients with refractory metastatic breast cancer (MBC). Larotaxel (XRP9881) is a novel taxoid with preclinical activity…”
Get full text

What the specific tools of geriatrics and oncology can tell us about the role and status of geriatricians in a pilot geriatric oncology program by Sifer-Rivière, L., Saint-Jean, O., Gisselbrecht, M., Cudennec, T., Girre, V.

“…Pilot Oncogeriatric Coordination Units (UPCOGs) were created by the French National Cancer Institute (INCA) in order to implement routine geriatric assessment…”
Get full text

Potential drug interactions in elderly cancer patients by Girre, V, Arkoub, H, Puts, M.T.E, Vantelon, C, Blanchard, F, Droz, J.P, Mignot, L

“…Abstract Introduction Drug interaction constitutes a major challenge in elderly cancer patients. This study investigated the number and types of medications…”
Get full text

Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study by Alexandre, J., Rey, E., Girre, V., Grabar, S., Tran, A., Montheil, V., Rabillon, F., Dieras, V., Jullien, V., Hérait, P., Pons, G., Treluyer, J.-M., Goldwasser, F.

“…Background: We hypothesized that cancer-related inflammation might increase the risk of febrile neutropenia (FN) induced by docetaxel (DCX, Taxotere), by both…”
Get full text

Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study by Puts, M.T.E, Monette, J, Girre, V, Wolfson, C, Monette, M, Batist, G, Bergman, H

“…Abstract Research on the use of health care by older newly-diagnosed cancer patients is sparse. We investigated whether frailty predicts hospitalization,…”
Get full text

Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age by Pierga, J.-Y., Girre, V., Laurence, V., Asselain, B., Diéras, V., Jouve, M., Beuzeboc, P., Fourquet, A., Nos, C., Sigal-Zafrani, B., Pouillart, P.

“…From 1981 to 1995, 1755 patients aged 70 years or over who had nonmetastatic unilateral breast carcinoma received curative local or regional treatment in our…”
Get full text

Clinical experience of cancer specialists and geriatricians involved in cancer care of older patients: A qualitative study by Puts, M.T.E, Girre, V, Monette, J, Wolfson, C, Monette, M, Batist, G, Bergman, H

“…Abstract Introduction Cancer is an important health problem in older persons. The aim of this study was to explore how cancer specialists and geriatricians…”
Get full text

P110 Medication interactions in older cancer patients, are they so frequent? by Girre, V, Arkoub, H, Vantelon, C, Mignot, L

Get full text

Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer ( group) by Elie, C, Geay, J F, Morcos, M, Le Tourneau, A, Girre, V, Broët, P, Marmey, B, Chauvenet, L, Audouin, J, Pujade-Lauraine, E, Camilleri-Broët, S

“…Epidermal growth factor receptor 1 (EGFR-1) overexpression is usually described as linked with a worse prognosis in a variety of tumours of epithelial origin…”
Get full text

P85 Professional perceptions of geriatric oncology programmes: a qualitative and sociological study by Sifer-Rivière, L, Girre, V, Gisselbrecht, M, Saint-Jean, O

Get full text

A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours by Siegel-Lakhai, W S, Zandvliet, A S, Huitema, A D R, Tibben, M M, Milano, G, Girre, V, Diéras, V, King, A, Richmond, E, Wanders, J, Beijnen, J H, Schellens, J H M

“…This dose escalation study was designed to determine the recommended dose of the multi-targeted cell cycle inhibitor indisulam in combination with capecitabine…”
Get full text

Changes in functional status in older newly-diagnosed cancer patients during cancer treatment: A six-month follow-up period. Results of a prospective pilot study by Puts, M.T.E, Monette, J, Girre, V, Wolfson, C, Monette, M, Batist, G, Bergman, H

“…Abstract Objectives While the number of older cancer patients is expected to increase, little is known about their functional trajectories over time. A better…”
Get full text

Impact of anthracycline-based adjuvant chemotherapy on quality of life in women over 70 with estrogen receptor-negative breast carcinoma: Results from the unicancer gerico-06 Phase II multicentre program by Fourme, E, Girre, V, Rousseau, F, Rigal, O, Abadie-Lacourtoisie, S, Uwer, L, Mertens, C, Turbiez, I, Orsini, C, Brain, E

Get full text